Alix Final Dark Grey.png
 
 

“Driving Patient Impact”

 

 

Alix Ventures: Supporting early stage Life Science startups engineering biology to drive radical advances in human health

Born from our collective experience as founders, we set out to build the fund we wanted to raise from...

Thesis: Life Sciences is experiencing rapid innovation with the rise of new generation of companies known as “TechBio” (Melding Technology & Biology), a change we believe is leading to some of the most impactful solutions in decades. Our passion is to help build transformative companies ahead of this revolution to significantly impact the quality & effectiveness of patient care. We aim to partner with passionate, accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in Life Sciences.

Team:  Our entire team is built of Life Science Founders with experience in raising capital, scaling teams, running labs, partnering with Pharma, & the many fires that consist of operating an early stage company. Founders, we’d love to partner with you along the journey & help translate daunting ideas into world shaping innovations - here’s to a better brighter future for patients! 

SAB: Composed of Bioengineering PhDs turned Founders, our Scientific Advisory Board provides deep technical expertise & fluency across a wide variety of Life Science sub-domains from platforms for “Novel Applications” (Therapeutics/Diagnostics) to “Bio-Economy Infrastructure” (Tools/Services/Manufacturing). Let’s talk science!

Support: Helping our founders is our utmost priority. To tackle the many challenges ahead, we’ve curated a full platform of resources to help with customer introductions, fundraising, & team building, amongst others. In addition, dedicated to supporting our portfolio is our operating partner - Mark Pulido (5x CEO - previously of Novartis, McKesson, & Ability) & our extensive network of industry executives spanning Top 25 Pharma, major health systems, & large Payors.

Limited Partners: Anchored by leading strategic LPs making up some of the best venture capital firms in the world, veteran founders, & industry experts. Alix is here to fill the void for early stage Life Science capital.

___________________________________________________________________________________________

Portfolio: Current Investments | Thesis Building: Research & Anti-Requests for Startups

Credo: The Biology of Business | Questions?: Visit FAQ | Investment Process: Download

___________________________________________________________________________________________

BIOS Community: BIOS Commons (1000+ Members) /  BIOS Angels (World’s First TechBio Angel Investing Syndicate)

Content: BIOS Medium (Top VC Writer) / BIOS Podcast (Top 100 Podcast) /  BIOS Daily Newsletter (25K+ Subscribers)

___________________________________________________________________________________________